Provided is an adeno-associated virus (AAV) comprising an AAVrh10 capsid having a sequence of amino acids 1 to 738 of a specified sequence or a sequence which is at least 95% identical therewith, a minigene having AAV inverted terminal repeats (ITRs), and a heterologous gene operably linked to regulatory sequences which direct its expression in a host cell.